This conference will encompass six sessions in two days. Each will focus on a different area of Drug Discovery from selecting compounds for the corporate collection, liquid handling and detection technologies, plus advances in assay development and screening. Two sessions will address the biochemistry of two important different target classes: Enzymes and G-protein coupled receptors. Biopharmaceuticals will form the sixth session. As with our highly successful meeting in 2007, attendees will hear world class speakers discussing the challenges facing the drug discovery scientist. The scientific sessions will be complemented by plenary keynote presentations from two of the field's foremost researchers, a poster session and a vendor exhibition with over 80 exhibitors.
Explore
Membership
